Journal article · 2026 · Open access

Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023

Alfred Simkin, Salehe S. Mandai, Abebe Alemu Fola, Neeva Wernsman Young, Jacob Marglous, Dativa Pereus, Catherine Bakari, Rashid A. Madebe, Misago D. Seth, Rule B. Mrengela, Angelina J. Kisambale, Gervas A. Chacha and 15 more

Frontiers in Genetics, 17, 1776108 · Published 2 June 2026 · DOI 10.3389/fgene.2026.1776108

Open PDFView at the publisherCite this paper

In brief

“Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023” is a 2026 journal article by Alfred Simkin and 26 co-authors, published in Frontiers in Genetics. OpenAlex counts 4 citations as of 19 November 2026, which puts it in the top 3% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Genetics.

Citations
4
Most cited in
2026 (4)
Field-weighted impact
14.78
References
34
Authors
27

Abstract

Artemisinin-based combination therapies (ACTs) remain the cornerstone of malaria treatment, yet the emergence of artemisinin partial resistance (ART-R) in Africa threatens their efficacy. ART-R is primarily associated with mutations in Plasmodium falciparum kelch13 (K13), notably R561H, which has been linked to delayed parasite clearance in East Africa. We genotyped 2,866 P. falciparum isolates from seven districts in Tanzania’s Kagera region (2021–2023) using 121 molecular inversion probes (MIP) targeting key resistance loci to characterize trends in ART-R and other resistance markers. The WHO-validated K13 mutation R561H persisted in border districts of Karagwe and Kyerwa, with prevalence ranging from 14% to 26%, and appeared for the first time in Muleba in 2022 (10.0%) and Bukoba rural district (0.7%) in 2023, indicating eastward spread toward Lake Victoria. Regional prevalence of R561H rose from 5.5% in 2021 to 6.9% in 2023. Additional validated (A675V) and candidate (V568G, P441L) mutations were detected at low frequencies. Markers associated with reduced sensitivity to partner drugs showed minimal change. Early DHFR and DHPS mutations were near fixation and high-level resistance markers (DHFR I164L and DHPS A581G) exhibited marked gradients. These latest mutations are significantly spatially colocalized (weighted spearman R 2 = 0.58, P = 0.045) and co-occur within a number of individual genomes. These results highlight notable variation in mutation prevalence and underscore the importance of high-resolution surveillance to identify emerging hotspots and guide targeted interventions. Sustained molecular monitoring is critical to inform treatment policy, preserve ACT efficacy, and mitigate the risk of widespread resistance across East Africa.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Simkin, A., Mandai, S. S., Fola, A. A., Young, N. W., Marglous, J., Pereus, D., Bakari, C., Madebe, R. A., Seth, M. D., Mrengela, R. B., Kisambale, A. J., Chacha, G. A., Mandara, C. I., Francis, F., Mbwambo, D., Garimo, I. A., Chacky, F., Aaron, S., Lusasi, A., . . . Bailey, J. A. (2026). Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023. Frontiers in Genetics, 17, 1776108. https://doi.org/10.3389/fgene.2026.1776108

MLA 9

Simkin, Alfred, et al. “Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023.” Frontiers in Genetics, vol. 17, 2026, p. 1776108. https://doi.org/10.3389/fgene.2026.1776108.

Chicago

Simkin, Alfred, Salehe S. Mandai, Abebe Alemu Fola, Neeva Wernsman Young, Jacob Marglous, Dativa Pereus, Catherine Bakari, et al. 2026. “Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023.” Frontiers in Genetics 17: 1776108. https://doi.org/10.3389/fgene.2026.1776108.

Harvard

Simkin, A. et al. (2026) ‘Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023’, Frontiers in Genetics, 17, p. 1776108. doi:10.3389/fgene.2026.1776108.

IEEE

A. Simkin et al., “Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023,” Frontiers in Genetics, vol. 17, p. 1776108, 2026, doi: 10.3389/fgene.2026.1776108.

BibTeX

@article{simkin2026temporal,
  title     = {{Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023}},
  author    = {Simkin, Alfred and Mandai, Salehe S. and Fola, Abebe Alemu and Young, Neeva Wernsman and Marglous, Jacob and Pereus, Dativa and Bakari, Catherine and Madebe, Rashid A. and Seth, Misago D. and Mrengela, Rule B. and Kisambale, Angelina J. and Chacha, Gervas A. and Mandara, Celine I. and Francis, Filbert and Mbwambo, Daniel and Garimo, Issa Ally and Chacky, Frank and Aaron, Sijenunu and Lusasi, Abdallah and Molteni, Fabrizio and Njau, Ritha and Kajange, Stella and Nhiga, Samwel L. and Mohamed, Ally and Juliano, Jonathan J. and Ishengoma, Deus S. and Bailey, Jeffrey A.},
  journal   = {Frontiers in Genetics},
  year      = {2026},
  volume    = {17},
  pages     = {1776108},
  doi       = {10.3389/fgene.2026.1776108},
  url       = {https://doi.org/10.3389/fgene.2026.1776108}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control

  • Plasmodium falciparum
  • antimalarial drug resistance
  • dihydrofolate reductase mutations
  • dihydropteroate synthase mutations
  • artemisinin-based combination therapy
  • Kagera Region

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Simkin, A., Mandai, S. S., Fola, A. A., Young, N. W., Marglous, J., Pereus, D., Bakari, C., Madebe, R. A., Seth, M. D., Mrengela, R. B., Kisambale, A. J., Chacha, G. A., Mandara, C. I., Francis, F., Mbwambo, D., Garimo, I. A., Chacky, F., Aaron, S., Lusasi, A., . . . Bailey, J. A. (2026). Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021–2023. Frontiers in Genetics, 17, 1776108. https://doi.org/10.3389/fgene.2026.1776108

How many times has this paper been cited?

4 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Genetics: sign in and open the PDF from this page.

Who wrote this paper?

Alfred Simkin, Salehe S. Mandai, Abebe Alemu Fola, Neeva Wernsman Young, Jacob Marglous, Dativa Pereus, Catherine Bakari, Rashid A. Madebe, Misago D. Seth, Rule B. Mrengela, Angelina J. Kisambale, Gervas A. Chacha and 15 more.

What is the DOI of this paper?

10.3389/fgene.2026.1776108, permanently at https://doi.org/10.3389/fgene.2026.1776108. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.